Results 21 to 30 of about 116,541 (310)

Economic evaluation of human papillomavirus vaccination in the United Kingdom. [PDF]

open access: yes, 2008
OBJECTIVE: To assess the cost effectiveness of routine vaccination of 12 year old schoolgirls against human papillomavirus infection in the United Kingdom. DESIGN: Economic evaluation. SETTING: UK. Population Schoolgirls aged 12 or older.
Choi, Yoon Hong   +2 more
core   +1 more source

Detection of Human Papillomavirus Type 16 DNA and of Antibodies to Human Papillomavirus Type 16 Proteins in Children

open access: yesIntervirology, 1997
We have measured markers of human papillomavirus type 16 (HPV 16) infection in children (1-10 years of age) who were hospitalized for reasons unrelated to papillomavirus infection. Genital and buccal swabs obtained from 79 children were tested for the presence of HPV 16 DNA by PCR.
K, Mund   +7 more
openaire   +2 more sources

Human papillomavirus genotype distribution and cervical squamous intraepithelial lesions among high-risk women with and without HIV-1 infection in Burkina Faso. [PDF]

open access: yes, 2006
Human papillomavirus (HPV) infection and cervical squamous intraepithelial lesions (SILs) were studied in 379 high-risk women. Human papillomavirus DNA was detected in 238 of 360 (66.1%) of the beta-globin-positive cervical samples, and 467 HPV isolates ...
Costes-Martineau, V   +30 more
core   +1 more source

HPV-18 transformed cells fail to arrest in G1 in response to quercetin treatment [PDF]

open access: yes, 2005
Previous work with primary human keratinocytes demonstrated that quercetin, a potent mutagen found in high levels in bracken fern (Pteridium aquilinum), arrested cells in G1 with concomitant elevation of the cyclin-dependent kinase inhibitor (cdki ...
Beniston, R.G., Campo, M.S.
core   +1 more source

Oral Human Papillomavirus Infection Before and After Treatment for Human Papillomavirus 16–Positive and Human Papillomavirus 16–Negative Head and Neck Squamous Cell Carcinoma [PDF]

open access: yesClinical Cancer Research, 2008
Abstract Purpose: Oral human papillomavirus (HPV) infection is a risk factor for head and neck squamous cell carcinoma (HNSCC), and is a concern for patients with HPV-positive HNSCC and their partners. The prevalence of oral HPV infection before and after cancer therapy was investigated among patients with HPV16-positive and HPV16 ...
Yuri, Agrawal   +6 more
openaire   +2 more sources

The E6E7 oncoproteins of cutaneous human papillomavirus type 38 interfere with the interferon pathway [PDF]

open access: yes, 2008
Non-melanoma skin cancer is the most frequent malignancy in Caucasian populations. Evidence suggests the involvement of cutaneous Human Papillomavirus (HPV) of the genus beta () in this disease. The ability of E6 and E7 of mucosal HPV to promote cellular
Tommasino, M.   +13 more
core   +1 more source

Role of antibodies to human papillomavirus 16 in prostate cancer: A seroscreening by peptide microarray

open access: yesTumor Biology, 2017
Evidence is accumulating in estimating the potential role of human papillomavirus infection in prostate carcinogenesis. However, the results remain inconclusive.
Xiaojun Zhao   +5 more
doaj   +1 more source

Human papillomavirus type 16 in head and neck carcinogenesis [PDF]

open access: yesReviews in Medical Virology, 2005
The aetiology of squamous cell carcinomas of the head and neck (HNSCC) is multifactorial. Oncogenic human papillomaviruses (HPVs), a causative agent in uterine cervical cancer, have also been repeatedly detected in HNSCC, especially in squamous cell carcinomas of tonsils.
Renwei, Chen   +2 more
openaire   +2 more sources

Human papillomavirus 16 L2 inhibits the transcriptional activation function, but not the DNA replication function, of HPV-16 E2 [PDF]

open access: yes, 2005
In this study we analysed the outcome of the interaction between HPV-16 L2 and E2 on the transactivation and DNA replication functions of E2. When E2 was expressed on its own, it transactivated a number of E2-responsive promoters but co-expression of L2 ...
Morgan, I.M.   +11 more
core   +1 more source

Elimination of Human Papillomavirus 16-Positive Tumors by a Mucosal rAd5 Therapeutic Vaccination in a Pre-Clinical Murine Study. [PDF]

open access: yesVaccines (Basel)
Therapeutic vaccination can harness the body’s cellular immune system to target and destroy cancerous cells. Several treatment options are available to eliminate pre-cancerous and cancerous lesions caused by human papillomaviruses (HPV), but may ...
Braun MR   +5 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy